Below you will find news about Coala Life’s products, research and other topics of interest to Coala’s operations.
For press releases concerning Coala Life AB, see our investor page.
Non-invasive Coala Heart Monitor has been validated for diagnostic accuracy, compared to reference standard 12-lead-electrocardiogram, to help detect atrial tachyarrhythmia and atrial fibrillation....
Read more
According to results from the triennial AMA Digital Health Research survey, published by American Medical Association this autumn, improved clinical outcomes and work efficiency are key drivers for...
Read more
Coala-Life Group AB (publ), has today entered into an agreement to acquire 100 percent of the shares in Vitrics Management Group Inc (“Vitrics”) for a purchase price of USD 4.5 million on a cas...
Read more
Coala Life announces today that the US Food & Drug Administration (FDA) has cleared additional indications and uses for the Coala Heart Monitor. The new FDA 510k clearance enables the system to...
Read more
On March 31 Philip Siberg, Co-founder of Coala Life, presented the latest developments in the company at Redeye Digital Health Day 2022. The presentation can be seen through the player below or ...
Read more